Randomized phase 2 study of nab-paclitaxel and gemcitabine with or without tocilizumab as first-line treatment in patients with advanced pancreatic cancer (PACTO)

被引：0
|
作者：
Chen, Inna Markovna
Johansen, Julia S.
Theile, Susann
Madsen, Kasper
Dajani, Olav
Lorentzen, Torben
Zimmers, Teresa
Nielsen, Dorte
机构：
[1] Copenhagen Univ Hosp Herlev & Gentofte, Herlev, Denmark
[2] Oslo Univ Hosp, Oslo, Norway
[3] Indiana Univ Sch Med, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4147
引用
收藏
页数：1
相关论文
共 50 条
  • [21] NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer
    Nichetti, Federico
    Rota, Simone
    Ambrosini, Paolo
    Pircher, Chiara
    Gusmaroli, Eleonora
    Busset, Michele Droz Dit
    Pusceddu, Sara
    Sposito, Carlo
    Coppa, Jorgelina
    Morano, Federica
    Pietrantonio, Filippo
    Di Bartolomeo, Maria
    Mariani, Luigi
    Mazzaferro, Vincenzo
    de Braud, Filippo
    Niger, Monica
    JAMA NETWORK OPEN, 2024, 7 (01)
  • [22] The Efficacy and Safety of PD-1 Inhibitors Combined with Nab-Paclitaxel Plus Gemcitabine versus Nab-Paclitaxel Plus Gemcitabine in the First-Line Treatment of Advanced Pancreatic Cancer: A Retrospective Monocentric Study
    Zhang, Feng
    Wang, Yuyang
    Yang, Fangfang
    Zhang, Yuming
    Jiang, Man
    Zhang, Xiaochun
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 535 - 546
  • [23] Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma
    Trestini, Ilaria
    Carbognin, Luisa
    Peretti, Umberto
    Sperduti, Isabella
    Caldart, Alberto
    Tregnago, Daniela
    Avancini, Alice
    Auriemma, Alessandra
    Orsi, Giulia
    Pilotto, Sara
    Frulloni, Luca
    Capurso, Gabriele
    Bria, Emilio
    Reni, Michele
    Tortora, Giampaolo
    Milella, Michele
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] First-line Nab-paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer from Routine Clinical Practice
    Vogel, Arndt
    Pelzer, Uwe
    Salah-Eddin, Al-Batran
    Koester, Wolf
    IN VIVO, 2014, 28 (06): : 1135 - 1140
  • [25] Safety and efficacy of first-line gemcitabine plus nab-paclitaxel for elderly metastatic pancreatic cancer patients
    Pecora, I.
    Vivaldi, C.
    Rovesti, G.
    Catanese, S.
    Salani, F.
    Gardini, A. Casadei
    Massa, V.
    Bernardini, L.
    Riggi, M.
    Andrikou, K.
    Rapposelli, I.
    Formica, V.
    Cesario, S.
    Caccese, M.
    Lencioni, M.
    Vasile, E.
    Falcone, A.
    Fornaro, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S151 - S151
  • [26] Second-Line Gemcitabine Plus Nab-Paclitaxel for Patients with Unresectable Advanced Pancreatic Cancer after First-Line FOLFIRINOX Failure
    Mita, Naoki
    Iwashita, Takuji
    Uemura, Shinya
    Yoshida, Kensaku
    Iwasa, Yuhei
    Ando, Nobuhiro
    Iwata, Keisuke
    Okuno, Mitsuru
    Mukai, Tsuyoshi
    Shimizu, Masahito
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (06)
  • [27] Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis
    Riedl, J. M.
    Posch, F.
    Horvath, L.
    Gantschnigg, A.
    Renneberg, F.
    Schwarzenbacher, E.
    Moik, F.
    Barth, D.
    Stotz, M.
    Schaberl-Moser, R.
    Pichler, M.
    Stoeger, H.
    Greil, R.
    Djanani, A.
    Schlick, K.
    Gerger, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S942 - S942
  • [28] Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer
    Pressiani, Tiziana
    Balsano, Rita
    Giordano, Laura
    Milella, Michele
    Bergamo, Francesca
    Bozzarelli, Silvia
    Noventa, Silvia
    Ferrrari, Daris
    Scartozzi, Mario
    Parra, Hector Soto
    Auriemma, Alessandra
    Solda, Caterina
    Zaniboni, Alberto
    Zecchetto, Camilla
    Rizzato, Mario Domenico
    Rimassa, Lorenza
    Santoro, Armando
    EUROPEAN JOURNAL OF CANCER, 2024, 207
  • [29] A phase I study of first-line L-glutamine (Gln) with gemcitabine (gem) and nab-paclitaxel (nab-p) in advanced pancreatic cancer (GlutaPanc)
    Davelaar, John
    Tighiouart, Mourad
    Hendifar, Andrew Eugene
    Osipov, Arsen
    Moshayedi, Natalie
    Placencio-Hickok, Veronica
    Bhowmick, Neil
    Gong, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [30] The role of response as a predictor of improved outcome in advanced pancreatic cancer patients treated with first-line gemcitabine plus nab-paclitaxel
    Chiaravalli, M.
    Bensi, M.
    Di Stefano, B.
    Bagala, C.
    Spring, A.
    Ribelli, M.
    Maratta, M.
    Tortora, G.
    Salvatore, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S143 - S143
12345